Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
SLGL
SLGL
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
SLGL News
Palvella Therapeutics Stock Soars to $114.69 Following Pipeline Developments
Dec 31 2025
NASDAQ.COM
What’s Causing the Decline of Small Cap Sol-Gel Tech Stock Today?
Dec 17 2025
Benzinga
Sol-Gel Technologies' SGT-210 Fails to Show Efficacy in Darier Disease Trial
Dec 17 2025
Globenewswire
Sol-Gel Technologies Halts SGT-210 Development, Shifts Focus to Other Studies
Dec 17 2025
Newsfilter
Booking Holdings Expected to Surge by 12%? Check Out 10 Leading Analyst Predictions for Monday
Oct 27 2025
Benzinga
Implications of Health Canada's EPSOLAY Approval for Sol-Gel Technologies' Stock
Sep 05 2025
NASDAQ.COM
Sol-Gel Stock Soars Over 150% - Will Upcoming Q4 Clinical Data Support Continued Growth?
Aug 21 2025
NASDAQ.COM
Sol-Gel Reports First Quarter 2025 Results
May 23 2025
Yahoo Finance
Sol-Gel Technologies reports Q1 results
May 23 2025
SeekingAlpha
Upcoming Stock Splits This Week (May 5 to May 9) – Stay Invested
May 05 2025
TipRanks
Biotech Alert: Searches spiking for these stocks today
Dec 26 2024
Business Insider
US Stocks Gain, Nasdaq Surges Over 100 Points
Dec 24 2024
Benzinga
Why Carbon Revolution Shares Are Trading Higher By Around 62%; Here Are 20 Stocks Moving Premarket
Dec 24 2024
Benzinga
Sol-Gel Announces 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Requirement
Nov 20 2024
Newsfilter
Sol-Gel Reports Third Quarter 2024 Financial Results and Provides Corporate Updates
Nov 15 2024
Newsfilter
All You Need to Know About SolGel Technologies (SLGL) Rating Upgrade to Strong Buy
Aug 27 2024
NASDAQ.COM
Show More News
